Skip to main content

Table 1 Demographic, tumor and treatment characteristics of the 70 patients

From: Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control

Characteristic N (%)
Age (y)  
  Median 61
  Range 41-91
Gender  
  Male 62
  Female 8
Primary site  
  Oral cavity 8
  Oropharynx 31
  Hypopharynx 17
  Larynx 10
  Nasopharynx 3
  Unknown primary 1
Tumor stage  
  T0 1
  T1 5
  T2 22
  T3 25
  T4 17
Nodal stage  
  N0 18
  N1 16
  N2a 3
  N2b 20
  N2c 8
  N3 5
Overall stage  
  I 1
  II 15
  III 9
  IV 45
Radiotherapy  
  Step and Shoot IMRT 65
  Volumetric Modulated Arc Therapy 5
Chemotherapy  
  Concurrent  
  Cisplatin 22
  Carboplatin/5-Fu 7
  Cetuximab 12
  Induction + concurrent 7
No chemotherapy 22